BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 3, 2021
View Archived Issues
Algernon repurposes a psychedelic drug as potential treatment for stroke
Read More
Akari announces development of its second clinical candidate, votucalis
Read More
New mouse model points to mitochondrial dynamics as key to neurodegeneration
Read More
BiomX reports first-in-human data with phage therapy candidate BX-002
Read More
Kira initiates first-in-human study of P-014 for complement-mediated diseases
Read More
FDA approves Posimir for post-surgical pain following arthroscopic subacromial decompression
Read More
CSL Behring initiates Australian study of CSL-760 to treat serious cases of COVID-19
Read More
Annamycin shows significant therapeutic benefit in metastatic osteosarcoma animal model
Read More
Cassava Sciences presents interim analysis data for simufilam in patients with Alzheimer's disease
Read More
University of Southern California and collaborators patent opioid receptor agonists
Read More
BioCardia announces pipeline updates and milestones
Read More
Phase I data presented for AXL inhibitor DS-1205c plus osimertinib in EGFR-mutated NSCLC
Read More
Curis initiates phase II LUCAS study of CA-4948 as treatment for anemia in MDS
Read More
DexTech expands preclinical program to evaluate OsteoDex in multiple myeloma
Read More
Tyvyt approved in China for first-line nonsquamous NSCLC
Read More
"Expansion sequencing" gives elbow room to in situ transcriptomics
Read More
Dual EGFR/LRG5 blockade with MCLA-158 shows promise in phase I study in metastatic CRC
Read More
Botanix reports data from phase IIa study of BTX-1801 for S. aureus nasal decolonization
Read More
UB-612 multitope peptide-based vaccine against COVID-19 enters phase II trials in Taiwan
Read More
Targeting ketohexokinase as new therapeutic strategy in NAFLD
Read More
Publication details phase III results with Gam-COVID-Vac (Sputnik V) vaccine
Read More
NSUN2 is a prognostic biomarker in NSCLC
Read More
Vaccitech begins phase Ib/IIa study of VTP-300 for chronic hepatitis B infection
Read More